Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated EV71 vaccine (KMB-17) Phase 4 study
NCT02999828Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Inactivated enterovirus 71 vaccine (KMB-17) in hand, foot, and mouth disease (HFMD), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Incidence of treatment adverse events at 24 months. Status: unknown.
02
Drugs
Inactivated enterovirus 71 vaccine (KMB-17)
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on NCT02999828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02999828.